Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [2]
        • LPEP Programme
        • PEP++ project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP [1]
      • PEP4LEP project
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

More on Autochthonous Leprosy in the United States.

Pieters T, Meredith A, Braig H. The New England journal of medicine. 2023; 389 (10) : 963.
Publication

More on Autochthonous Leprosy in the United States. Reply.

Adler B, Ochoa M. The New England journal of medicine. 2023; 389 (10) : 963-964.
Publication

Hansen’s Disease in Children

Leonard JS, Fairley JK. Springer International Publishing. Hansen’s Disease. 2023;
Publication

Leprosy Agents and Principal Methods of Detection, Identification, and Characterization of the Leprosy Agents

Braet SM, Rosa PS, Spencer JS, et al. Springer International Publishing. Hansen’s Disease. 2023;
Publication

Renal Abnormalities in Leprosy: Understanding the Scope and Implication

Pandey S, Agarwal S, Raizada A, et al. MAK HILL Publications. International Journal of Tropical Medicine . 2023; 18 (1) : 74-80.
Download PDF
Publication

Patologia da hanseníase e a importância do diagnóstico histopatológico

Soares CT, Souza VNBD. Instituto Lauro de Souza Lima. Hansenologia Internationalis: hanseníase e outras doenças infecciosas. 2023;
Download PDF
Publication

Intervención educativa para el conocimiento sobre lepra en pacientes del Consultorio 15 Nuevitas

Cabreja-Heredia M, Ríos-Escobar R, Suárez-Ramos L, et al. Revista de Ciencias Médicas de Pinar del Río. 2023;
Download PDF
Publication

Lepra lepromatosa, antigua enfermedad con repercusiones actuales

Tuta-Quintero E. A, Ariza-Gómez L. Y. Medicina Interna de México. 2023; 39 (3) : 586-589.
Publication

Borderline type leprosy with variation of clinical manifestations and histopathology: two case reports

Karmila G. A. A. D, Rusyati L. M. M, Saputra H, et al. Bali Medical Journal. 2023; 12 (3) : 2440-2445.
Download PDF
Publication

Role of cytopathology in diagnosing phaeohyphomycosis masquerading as nerve abscess in a lepromatous leprosy patient: A case report.

Yadav S, Chandana B, Panwar H, et al. International journal of surgery case reports. 2023;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 59
  • Next page ››
Subscribe to Diagnosis

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD